A detailed history of Ubs Group Ag transactions in Opko Health, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 846,424 shares of OPK stock, worth $1.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
846,424
Previous 666,116 27.07%
Holding current value
$1.39 Million
Previous $832,000 51.56%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.21 - $1.68 $218,172 - $302,917
180,308 Added 27.07%
846,424 $1.26 Million
Q2 2024

Aug 13, 2024

SELL
$1.21 - $1.42 $448,346 - $526,158
-370,534 Reduced 35.74%
666,116 $832,000
Q1 2024

May 13, 2024

SELL
$0.87 - $1.57 $327,685 - $591,340
-376,650 Reduced 26.65%
1,036,650 $1.24 Million
Q4 2023

Feb 09, 2024

BUY
$1.23 - $1.63 $491,126 - $650,842
399,290 Added 39.38%
1,413,300 $2.13 Million
Q3 2023

Nov 09, 2023

BUY
$1.5 - $2.17 $845,319 - $1.22 Million
563,546 Added 125.1%
1,014,010 $1.62 Million
Q2 2023

Aug 11, 2023

BUY
$1.37 - $2.17 $192,202 - $304,437
140,294 Added 45.23%
450,464 $977,000
Q1 2023

May 12, 2023

BUY
$1.06 - $1.61 $91,160 - $138,460
86,000 Added 38.36%
310,170 $452,000
Q4 2022

Feb 08, 2023

BUY
$1.05 - $2.01 $5,913 - $11,320
5,632 Added 2.58%
224,170 $280,000
Q3 2022

Nov 10, 2022

BUY
$1.81 - $2.81 $85,158 - $132,207
47,049 Added 27.44%
218,538 $413,000
Q2 2022

Aug 10, 2022

SELL
$2.33 - $3.61 $1.65 Million - $2.56 Million
-707,897 Reduced 80.5%
171,489 $434,000
Q1 2022

May 16, 2022

BUY
$2.87 - $4.93 $453,273 - $778,619
157,935 Added 21.89%
879,386 $3.03 Million
Q4 2021

Feb 14, 2022

SELL
$3.52 - $5.15 $337,307 - $493,503
-95,826 Reduced 11.73%
721,451 $3.47 Million
Q3 2021

Nov 15, 2021

BUY
$3.44 - $4.24 $106,461 - $131,219
30,948 Added 3.94%
817,277 $2.98 Million
Q2 2021

Aug 13, 2021

SELL
$3.33 - $4.55 $2.4 Million - $3.28 Million
-721,691 Reduced 47.86%
786,329 $3.18 Million
Q1 2021

May 12, 2021

BUY
$4.19 - $5.99 $3.32 Million - $4.75 Million
793,262 Added 110.98%
1,508,020 $6.47 Million
Q4 2020

Feb 11, 2021

SELL
$3.27 - $4.87 $6.15 Million - $9.17 Million
-1,882,052 Reduced 72.48%
714,758 $2.82 Million
Q3 2020

Nov 12, 2020

BUY
$2.99 - $5.96 $6.52 Million - $13 Million
2,180,531 Added 523.81%
2,596,810 $9.58 Million
Q2 2020

Jul 31, 2020

SELL
$1.15 - $3.41 $423,371 - $1.26 Million
-368,149 Reduced 46.93%
416,279 $1.42 Million
Q1 2020

May 01, 2020

SELL
$1.34 - $2.32 $947,192 - $1.64 Million
-706,860 Reduced 47.4%
784,428 $1.05 Million
Q4 2019

Feb 14, 2020

BUY
$1.42 - $2.17 $343,003 - $524,167
241,552 Added 19.33%
1,491,288 $2.19 Million
Q3 2019

Nov 14, 2019

BUY
$1.75 - $2.47 $894,321 - $1.26 Million
511,041 Added 69.18%
1,249,736 $2.61 Million
Q2 2019

Aug 14, 2019

SELL
$1.79 - $2.61 $1.09 Million - $1.59 Million
-608,010 Reduced 45.15%
738,695 $1.8 Million
Q1 2019

May 14, 2019

SELL
$2.42 - $3.83 $8,276 - $13,098
-3,420 Reduced 0.25%
1,346,705 $3.52 Million
Q4 2018

Feb 14, 2019

BUY
$2.46 - $3.87 $1.95 Million - $3.07 Million
794,513 Added 143.0%
1,350,125 $4.06 Million
Q3 2018

Nov 14, 2018

BUY
$3.29 - $6.29 $163,424 - $312,443
49,673 Added 9.82%
555,612 $1.92 Million
Q2 2018

Aug 14, 2018

SELL
$2.99 - $4.99 $4.29 Million - $7.17 Million
-1,435,999 Reduced 73.95%
505,939 $2.38 Million
Q1 2018

May 15, 2018

BUY
$3.11 - $5.12 $697,859 - $1.15 Million
224,392 Added 13.06%
1,941,938 $6.16 Million
Q4 2017

Feb 14, 2018

SELL
$4.61 - $7.04 $5.46 Million - $8.34 Million
-1,184,016 Reduced 40.81%
1,717,546 $8.42 Million
Q3 2017

Nov 14, 2017

BUY
$5.88 - $7.11 $9.83 Million - $11.9 Million
1,672,275 Added 136.04%
2,901,562 $19.9 Million
Q2 2017

Aug 14, 2017

BUY
N/A
451,063 Added 57.96%
1,229,287 $8.09 Million
Q1 2017

Nov 14, 2017

BUY
N/A
778,224
778,224 $6.23 Million

Others Institutions Holding OPK

About OPKO HEALTH, INC.


  • Ticker OPK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 771,960,000
  • Market Cap $1.27B
  • Description
  • OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...
More about OPK
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.